| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.75B | 23.90B | 25.93B | 22.68B | 14.25B | 14.08B |
| Gross Profit | 7.87B | 6.20B | 8.42B | 7.65B | 3.49B | 3.73B |
| EBITDA | 3.36B | 1.94B | 4.18B | 3.63B | 161.98M | 627.18M |
| Net Income | 1.44B | 1.18B | 2.26B | 2.42B | -249.47M | 53.27M |
Balance Sheet | ||||||
| Total Assets | 18.40B | 21.72B | 20.40B | 19.95B | 14.86B | 14.45B |
| Cash, Cash Equivalents and Short-Term Investments | 2.36B | 4.38B | 2.07B | 2.96B | 3.18B | 4.09B |
| Total Debt | 819.04M | 1.35B | 1.75B | 3.07B | 5.44B | 4.52B |
| Total Liabilities | 8.92B | 10.74B | 10.30B | 13.07B | 10.17B | 9.67B |
| Stockholders Equity | 9.49B | 10.98B | 10.10B | 6.88B | 4.69B | 4.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.14B | -254.63M | 1.98B | -1.65B | 2.17B |
| Operating Cash Flow | 0.00 | 3.60B | 1.18B | 2.34B | -1.49B | 2.30B |
| Investing Cash Flow | 0.00 | -314.40M | -1.56B | -105.31M | -222.11M | -138.95M |
| Financing Cash Flow | 0.00 | -1.04B | -543.06M | -2.48B | 781.24M | -1.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥8.36B | 7.54 | ― | 2.63% | -7.84% | -49.45% | |
72 Outperform | ¥120.93B | 14.76 | ― | 3.02% | -5.84% | -10.06% | |
70 Outperform | ¥16.07T | 70.09 | 8.95% | 1.88% | 5.02% | 2.02% | |
70 Outperform | ¥72.42B | 19.36 | ― | 3.05% | 8.87% | -12.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥1.88T | 134.28 | ― | 2.57% | 4.07% | 533.21% | |
51 Neutral | ¥126.79B | 44.14 | 2.26% | ― | 11.52% | 5786.05% |